FACS analysis of HeLa cells using GTX02717 SPTBN2 antibody [SPTBN2/2887R]. Blue : Primary antibody Red : Isotype control
SPTBN2 antibody [SPTBN2/2887R]
GTX02717
ApplicationsFlow Cytometry, ImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman
TargetSPTBN2
Overview
- SupplierGeneTex
- Product NameSPTBN2 antibody [SPTBN2/2887R]
- Delivery Days Customer9
- ApplicationsFlow Cytometry, ImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDSPTBN2/2887R
- Concentration200 ug/ml
- ConjugateUnconjugated
- Gene ID6712
- Target nameSPTBN2
- Target descriptionspectrin beta, non-erythrocytic 2
- Target synonymsbeta-III spectrin; glutamate transporter EAAT4-associated protein 41; GTRAP41; SCA5; SCAR14; spectrin beta chain, brain 2; spectrin beta chain, non-erythrocytic 2; spectrin beta III sigma 2; spectrin, non-erythroid beta chain 2; spinocerebellar ataxia 5 protein
- HostRabbit
- IsotypeIgG
- Scientific DescriptionSpectrins are principle components of a cells membrane-cytoskeleton and are composed of two alpha and two beta spectrin subunits. The protein encoded by this gene (SPTBN2), is called spectrin beta non-erythrocytic 2 or beta-III spectrin. It is related to, but distinct from, the beta-II spectrin gene which is also known as spectrin beta non-erythrocytic 1 (SPTBN1). SPTBN2 regulates the glutamate signaling pathway by stabilizing the glutamate transporter EAAT4 at the surface of the plasma membrane. Mutations in this gene cause a form of spinocerebellar ataxia, SCA5, that is characterized by neurodegeneration, progressive locomotor incoordination, dysarthria, and uncoordinated eye movements. [provided by RefSeq, Dec 2009]
- ReactivityHuman
- Storage Instruction2°C to 8°C
- UNSPSC12352203